The Reliability and Validity of the Figure of 8 Walk Test and Double Task Figure of 8 Walk Test in Persons With Stroke

Sponsor
Pamukkale University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05552885
Collaborator
(none)
28
1
10.6
2.6

Study Details

Study Description

Brief Summary

The validity of the dual-task F8W test in predicting falls in older adults has been confirmed. As far as we know, there are no studies evaluating the validity and reliability of the dual-task F8W test in stroke patients. Therefore, the aim of the study is to evaluate the validity and reliability of the F8W and dual-task F8W test in stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Evaluation

Detailed Description

Recently, the validity and reliability of assessment tools in which two tasks are performed simultaneously have been investigated. Although the utility of dual-task assessments in assessing falls in neurological diseases is uncertain, the reliability of dual-task assessments involving walking has shown quite good results. Stroke survivors have decreases in one or both (locomotor and cognitive) performances while walking and simultaneously performing a cognitive task. The tasks selected in dual-task evaluations may affect dual-task interactions, therefore, tasks that are compatible with daily living activities should be used in dual-task evaluations. A previous study confirmed the validity of the dual-task F8W test in predicting falls in older adults. Because of this reaason, stroke patients aged 50 and over will be included in the study.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
28 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Reliability and Validity of the Figure of 8 Walk Test and Double Task Figure of 8 Walk Test in Persons With Stroke
Anticipated Study Start Date :
Oct 10, 2022
Anticipated Primary Completion Date :
Feb 28, 2023
Anticipated Study Completion Date :
Aug 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Stroke patients

General cognitive level will be evaluated with the Standardized Mini Mental Test to determine the eligibility of the participants for the study. The American National Institutes of Health Stroke Scale will be applied to determine the stroke severity and functional status of the participants. The reliability and validity of the eight-shape gait test and the double-task octagonal gait test will be examined. The reliability of the tests will be evaluated by calculating the test-retest method, standard error measurement and minimum detectable change values. The initial test and retest will be evaluated two days apart. The concurrent validity of the tests will be evaluated by the correlation between the timed get-and-go test, the 10-meter walk test, and the modified four-square step test.

Other: Evaluation
The Standardized Mini Mental Test, The American National Institutes of Health Stroke Scale, the Figure of 8 Walk Test, the double-task octagonal gait test, the timed up-and-go test, the 10-meter walk test, and the modified four-square step test will be applied to the stroke patients.

Outcome Measures

Primary Outcome Measures

  1. Standardized Mini Mental Test [six months]

    It is a practical, short and standardized test that evaluates cognition in general. It consists of five subsections and 11 items: orientation, recording memory, attention and calculation, recall and language. A total of 30 points can be obtained from the test. Scores below the 23/24 threshold for the Turkish population indicate dementia (Güngen, Ertan, Eker, Yaşar, & Engin, 2002).

  2. National Institutes of Health Stroke Scale Score-NIHSS [six months]

    The scale used to determine the severity of stroke consists of a total of 11 items. The highest score of the scale is 36. On the scale, >17 points are severe, 8-16 points are moderate, and <8 points indicate mild stroke (Brott et al., 1989).

  3. Figure of 8 Walk Test (F8WT) [six months]

    Participants will be instructed to stand in the middle of two cones 1.52 m apart and walk around the cones at their normal walking pace, in the direction of their choice, in a figure eight, and stop when they reach the starting point. The time to complete the test will be recorded. The original F8W test also takes into account the number of steps and gait smoothness required to complete the task (Hess et al., 2010). Only the time to complete F8W will be used in this study, as time is more objective than smoothness and number of steps in evaluating changes in walking performance.

  4. Timed Up and Go Test (TUG) [six months]

    It is a valid and reliable tool that evaluates walking performance on flat roads in stroke individuals. The time it takes for an individual to complete 10 meters at normal walking speed at a distance of 14 m (the first and last 2 m distances are not considered) is recorded (Cheng, Nelson, Brooks, & Salbach, 2020).

  5. Modified Four Square Step Test [six months]

    It is a valid and reliable tool that evaluates the ability to take steps, change direction and turn in stroke individuals. Roos et al. It has been modified to reduce the risk of falling during testing. The test is applied by recording the time elapsed during the individual's stepping forward, backward and sideways in the areas marked from 1 to 4, which are glued to the ground in a square shape (Roos, Reisman, Hicks, & Rudolph, 2016).

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years to 85 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Being 50 years of age and older,

  • Having only one unilateral stroke at least 6 months prior to the study,

  • Being medically stable,

  • Being able to walk at least 10 meters with a cane or independently,

  • Getting 24 points or more from the Standardized Mini-Mental Test',

  • Being to be able to perform the cognitive task (subtraction) to be given during the evaluations.

Exclusion Criteria:
  • The presence of additional orthopedic, neurological or cardiovascular diseases that may affect balance and walking,

  • Uncorrected vision and hearing problems.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Pamukkale University Denizli Kınıklı/Pamukkale Turkey 20070

Sponsors and Collaborators

  • Pamukkale University

Investigators

  • Principal Investigator: Güzin Kara, PhD, Pamukkale University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Güzin Kara, Principal Investıgator, Pamukkale University
ClinicalTrials.gov Identifier:
NCT05552885
Other Study ID Numbers:
  • E-60116787-020-217378
First Posted:
Sep 23, 2022
Last Update Posted:
Sep 23, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 23, 2022